248 related articles for article (PubMed ID: 16270103)
1. The changing treatment paradigm in patients with newly diagnosed multiple myeloma: implications for nursing.
Tariman JD; Estrella SM
Oncol Nurs Forum; 2005 Nov; 32(6):E127-38. PubMed ID: 16270103
[TBL] [Abstract][Full Text] [Related]
2. [Treatment for multiple myeloma: current status and future strategy in Japan].
Iida S
Rinsho Ketsueki; 2008 Oct; 49(10):1368-73. PubMed ID: 18833921
[No Abstract] [Full Text] [Related]
3. Multiple myeloma patient care: treatment options and nursing considerations.
McGee L
ONS Connect; 2007; 22(8 Suppl):67-8. PubMed ID: 17824572
[No Abstract] [Full Text] [Related]
4. Advances in the treatment of multiple myeloma.
Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D
Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186
[No Abstract] [Full Text] [Related]
5. Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma.
Patriarca F; Sperotto A; Filì C; Zaja F; Prosdocimo S; Fanin R
Haematologica; 2002 Jul; 87(7):779-81. PubMed ID: 12091134
[TBL] [Abstract][Full Text] [Related]
6. Medical management update: multiple myeloma.
Stoopler ET; Vogl DT; Stadtmauer EA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 May; 103(5):599-609. PubMed ID: 17291793
[TBL] [Abstract][Full Text] [Related]
7. [Multiple myeloma: past, present and future].
Zulian GB
Rev Med Suisse Romande; 1989 Nov; 109(11):939-45. PubMed ID: 2688027
[No Abstract] [Full Text] [Related]
8. The role of autologous stem cell transplantation in the management of multiple myeloma.
Fermand JP; Brechignac S
Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889
[TBL] [Abstract][Full Text] [Related]
9. Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support.
Iversen PO; Wisløff F; Gulbrandsen N
Clin Nutr; 2010 Aug; 29(4):488-91. PubMed ID: 20044183
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow transplantation with immunotoxin purged marrow for multiple myeloma. Long term results in 14 patients with advanced disease.
Gobbi M; Tazzari PL; Cavo M; Tassi C; Grimaldi M; Meloni G; Di Nucci G; Vignetti M; Bolognesi A; Stirpe F
Bone Marrow Transplant; 1991; 7 Suppl 2():30. PubMed ID: 1878704
[No Abstract] [Full Text] [Related]
11. Multiple myeloma: a tailored therapy for elderly patients.
Pileri A; Palumbo A; Boccadoro M
Hematol Oncol; 1993; 11 Suppl 1():67-72. PubMed ID: 8486344
[No Abstract] [Full Text] [Related]
12. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
[TBL] [Abstract][Full Text] [Related]
13. NCCN: Multiple myeloma.
Traynor AE; Noga SJ;
Cancer Control; 2001; 8(6 Suppl 2):78-87. PubMed ID: 11760563
[TBL] [Abstract][Full Text] [Related]
14. Modern treatment options for elderly patients with multiple myeloma.
Görner M; Späth-Schwalbe E;
Onkologie; 2008 Jun; 31(6):335-42. PubMed ID: 18547977
[TBL] [Abstract][Full Text] [Related]
15. [High-dose melphalan in patients with multiple myeloma].
Moreau P; Le Bonniec M; Harousseau JL
Bull Cancer; 1999 Mar; 86(3):283-8. PubMed ID: 10210762
[TBL] [Abstract][Full Text] [Related]
16. [Current therapy concepts in patients with multiple myeloma].
Heyll A; Schneider P; Bauser U; Kobbe G; Hünerlitürkoglu A; Aul C; Haas R
Dtsch Med Wochenschr; 2000 Oct; 125(40):1201-9. PubMed ID: 11075253
[No Abstract] [Full Text] [Related]
17. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
[TBL] [Abstract][Full Text] [Related]
18. Novel approaches in the treatment of multiple myeloma.
Abedi M; Elfenbein GJ
Med Health R I; 2003 Aug; 86(8):231-5. PubMed ID: 14582216
[TBL] [Abstract][Full Text] [Related]
19. Myeloma and the newly diagnosed patient: a focus on treatment and management.
Rajkumar SV; Kyle RA; Gertz MA
Semin Oncol; 2002 Dec; 29(6 Suppl 17):5-10. PubMed ID: 12520478
[TBL] [Abstract][Full Text] [Related]
20. Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma.
Cogle CR; Moreb JS; Leather HL; Finiewicz KJ; Khan SA; Reddy VS; Wingard JR
Am J Hematol; 2003 Jul; 73(3):169-75. PubMed ID: 12827653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
